DOI:
10.1055/s-00000059
Pneumologie
LinksClose Window
References
Nowak AK, Lesterhuis WJ, Hughes BGM. et al.
DREAM: A phase II study of durvalumab with first line chemotherapy in mesothelioma – First results.
J Clin Oncol 2018;
36: 8503
DOI: 10.1200/JCO.2018.36.15_suppl.8503.
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.